Introduction
============

*Escherichia coli* are a common inhabitant of the intestinal tract of humans and animals and the most common cause of nosocomial- and community-acquired infections ([@B30]). Within the gastrointestinal tract, commensal *E.coli* can transfer its antibiotic-resistant genes to diverse microorganisms, such as pathogenic bacteria, especially when exposed to antimicrobials ([@B22]). The transfer of antibiotic-resistant genes was first described by [@B21] who isolated *E.coli* strains from the digestive tract of humans and animals. Over the years, this finding has been confirmed by numerous studies ([@B1]; [@B32]; [@B3]; [@B31]).

Humans become colonized and/or infected through physical contact, occupational exposure or food consumption. Food, especially of animal origin, is an important vehicle of antibiotic-resistant pathogens ([@B30]; [@B20]). Some studies have shown epidemiological relationships among different *E.coli* strains isolated from humans and foods and an increased number of resistant isolates ([@B29] [@B19]; [@B14]; [@B12]; [@B24]).

The aims of this study were to evaluate the antimicrobial susceptibility of *E.coli* strains isolated from humans and foods, to identify potential pathogenic strains and to determine the possible epidemiological relationship among them by pulsed-field gel electrophoresis (PFGE).

Materials and Methods
=====================

*Escherichia coli* Strains
--------------------------

A total of 84 *E.coli* isolates from human (48) and food (36) samples were evaluated. Human isolates were obtained from stool (39) and urine (9) samples of outpatients at two major hospitals in the city of Salvador, Brazil. At the Food Microbiology Research Laboratory of the Federal University of Bahia (UFBA) and at the Central Laboratory of Public Health Prof. Gonçalo Moniz (LACEN/BA), food isolates were obtained from meat (8), chicken meat (1), milk (2), dairy products (6) and ready-made meals (19) according to [@B8].

Antimicrobial susceptibility profile
------------------------------------

Susceptibility testing was carried out by a disc diffusion method according to the Clinical and Laboratory Standard Institute guidelines ([@B7]). The tested antibiotics (Laborclin, Paraná, Brazil) included ampicillin (10 μg), cephalothin (30 μg), cefotaxime (30 μg), ciprofloxacin (5 μg), gentamicin (10 μg), tetracycline (30 μg), chloramphenicol (30 μg), trimethoprim/sulfamethoxazole (1.25/23.75 μg), amoxicillin/clavulanic acid (20/10 μg), levofloxacin (5 μg) and ceftriaxone (30 μg). *E. coli* ATCC 25922 was used as a quality control. Multidrug resistance was defined as resistance to at least two classes of antimicrobial drugs ([@B13]).

Investigation of pathogenic serotypes
-------------------------------------

The *E. coli* isolates were screened by multiplex-PCR ([@B25]) with primers (IDT, USA) specific to the virulence genetic markers *ipaH, eae, stx, bfp,* LT and ST for *E. coli* enteroinvasive (EIEC), enteroaggregative (EAEC), enteropathogenic (EPEC), enterohemorrhagic (EHEC) and enterotoxigenic (ETEC), respectively, as described by [@B25] and [@B15]. The primers, the size of the amplification products (*i.e.*, amplicons) and the references used in the detection of the six virulence gene markers are shown in [Table 1](#t1){ref-type="table"}. The non-pathogenic *E. coli* K12 HB101 was used as a PCR negative control, and EPEC O111: H2, H34x ST ETEC, ETEC LT 52593, EIEC O144: H25, and EHEC EDL933 were used as positive controls.

###### Primers and amplicons size of the virulence genes searched in the 84 *E.coli* isolates studied.

  Virulence Gene   Serotype                                   Primers    Sequence (5′-3′)                  Size of product PCR   Reference
  ---------------- ------------------------------------------ ---------- --------------------------------- --------------------- -----------
  BFP gene         EPEC[a](#TFN1){ref-type="table-fn"}        EP1        CAA-TGG-TGC-TTG-CGC-TTG-CT        324                   [@B25]
                                                              EP2        GCC-GCT-TTA-TCC-AAC-CTG-GT                              
  LT gene          ETEC (LT)[b](#TFN2){ref-type="table-fn"}   ETLT1      GCG-ACA-AAT-TAT-ACC-GTG-CT        708                   [@B25]
                                                              ETLT2      CCG-AAT-TCT-GTT-ATA-TAT-GT                              
  Sta gene         ETEC (ST)[c](#TFN3){ref-type="table-fn"}   ETST1      CTG-TAT-TGT-CTT-TTT-CAC-CT        182                   [@B25]
                                                              ETST2      GCA-CCC-GGT-ACA-AGC-AGG-AT                              
  *ipaH*           EIEC[d](#TFN4){ref-type="table-fn"}        EI-1       GCT-GGA-AAA-ACT-CAG-TGC-CT        424                   [@B25]
                                                              EI-2       CCA-GTC-CGT-AAA-TTC-ATT-CT                              
  *eae*            EHEC[e](#TFN5){ref-type="table-fn"}        EH*eae*1   GTG-GCG-AAT-ACT-GGC-GAG-ACT-A     435                   [@B15]
                                                              EH*eae*2   GAT-CGT-AAC-GGC-TGC-CTG-ATA-TAA                         
  *hly*            EHEC[e](#TFN5){ref-type="table-fn"}        EH*hly*1   AGC-CGG-AAC-AGT-TCT-CTC-AG        526                   [@B15]
                                                              EH*hly*2   CCA-GCA-TAA-CAG-CCG-ATG-T                               

enteropathogenic;

enterotoxigenic the heat-labile enterotoxin (LT)-producing;

enterotoxigenic the heat-stable enterotoxin(STa)-producing;

enteroinvasive;

enterohemorrhagic.

Pulsed-Field Gel Electrophoresis (PFGE)
---------------------------------------

The Center for Disease Control and Prevention protocol for molecular subtyping of *E. coli* O157:H7 by PFGE was used ([@B4]). PFGE of *Xba*I-digested DNA (Sigma-Aldrich, USA) was performed on the isolates that were resistant to an antibiotic. Isolates exhibiting identical PFGE patterns were considered to be genetically indistinguishable, those exhibiting 1-3 band differences were considered to be closely related, and those exhibiting 4-6 band differences were considered to be possibly related.

Data Analysis
-------------

The *Xba*I (Sigma-Aldrich, USA) fingerprints were analyzed using GelCompar II software (Applied Maths, Kortrijk, Belgium). A similarity dendrogram was constructed by the unweighted pair group (UPGMA) method using the Dice similarity coefficient; the relatedness between the isolates was interpreted according to the method described by [@B23].

Ethics
------

This project was approved by the Research Ethical Committee of Department of Health of the State of Bahia (No. 0028.0053.000-09).

Results and Discussion
======================

Susceptibility profile
----------------------

The prevalence of antimicrobial resistance among the *E. coli* strains isolated from humans and foods is shown in [Table 2](#t2){ref-type="table"}. Overall, 29 (34.6%) of the isolates were resistant to at least one of the 11 antibiotics tested, two (2.4%) had an intermediate susceptibility, and 53 (63%) were pan-sensitive. Among those isolates recovered from humans (n = 48), 30 (62%) were susceptible to all the tested antibiotics, 13 (27%) were resistant to ampicillin, 13 (27%) were resistant to tetracycline, and 11 (23%) were resistant to trimethoprim/sulfamethoxazole. Among those isolates recovered from food, 23 (64%) were susceptible to all the antibiotics tested, 9 (25%) were resistant to tetracycline, 4 (11%) were resistant to ampicillin, and 2 (5%) had an intermediate resistance to cephalotin ([Table 2](#t2){ref-type="table"}).

###### Prevalence of antimicrobial resistance among *Escherichia coli* isolates from human and food source.

  Antibiotics                     \% Resistance          
  ------------------------------- --------------- ------ ------
  Ampicillin                      27.0            11.0   20.2
  Amoxicillin/Clavulanic acid     0               5.5    2.3
  Cephalotin                      4.0             8.3    6.0
  Cefotaxime                      2.0             0      1.2
  Ceftriaxone                     0               0      0
  Ciprofloxacin                   6.2             2.7    4.7
  Chloramphenicol                 6.2             2.7    4.7
  Gentamicin                      2.0             2.7    2.3
  Levofloxacin                    6.2             0      3.5
  Tetracycline                    27.0            25.0   26.0
  Trimethoprim/sulfamethoxazole   23.0            5.5    15.4

These results are consistent with those reported by [@B11], who found that human isolates had a higher resistance percentage to ampicillin, trimethoprim/sulfamethoxazole and tetracycline than to other drugs. Furthermore, [@B18] reported that the highest resistance percentage was to ampicillin, followed by trimethoprim/sulfamethoxazole.

In this study, the prevalence of tetracycline resistance was similar in *E. coli* isolates obtained from humans and foods, contrary to the results reported by [@B16], who investigated *E. coli* isolates obtained from foods, animals and humans in Germany. The authors found a higher rate of tetracycline resistance in *E. coli* isolated from animals and foods than in *E. coli* isolated from humans. However, in both studies, the rate of resistance to ampicillin was the second highest in the strains isolated from dietary sources. Ampicillin resistance has been widely observed even when the use antimicrobial agents is restricted, as reported by [@B10], who analyzed *E. coli* isolates obtained from animal feces living in organic farms.

In a similar study conducted by [@B11] in Denmark, the rate of tetracycline resistance was higher in *E. coli* isolates obtained from food than in those obtained from humans. In Denmark, tetracycline is used mainly in swine farms ([@B28]). [@B16] attributed this high rate of tetracycline resistance in *E. coli* isolates from food to the widespread use of antimicrobials during food production. According to the Brazilian Ministry of Agriculture, Livestock and Supply, the use of antimicrobials has not been allowed since 1998 (Ordinance No. 193 of 12.05.1998 repealed by the Normative Instruction number 26, 07.09.2009) ([@B5]).

The rate of antimicrobial resistance observed in this study among the *E. coli* isolates obtained from food was lower than that reported by [@B27], [@B26] and [@B2], who reported resistance rates close to 100%. Because of the use of antimicrobial agents in animal feed and the selective pressure that such drugs exert on the microorganisms, it is assumed that isolates obtained from foods of animal origin have a resistance profile that is superior to those from other food sources.

The percentage of human isolates that exhibited multidrug resistance was 77.7% (14/18); the percentage of food isolates with multidrug resistance was 45.5% (5/11) ([Table 3](#t3){ref-type="table"}). Similar results were described by [@B24], who found a higher proportion of multidrug resistant *E. coli* in human isolates than in food isolates.

###### Multiple antimicrobial drug resistance among *Escherichia coli* isolates by source.

  Antimicrobial                  \% resistant              
  ------------------------------ -------------- ---------- ---------
  AMP                            4.2 (2)        2.7 (1)    3.5 (3)
  TET                            4.2 (2)        13.8 (5)   8.3 (7)
  CFL                            0              0          0
  AMP TET                        2.0 (1)        0          1.2 (1)
  AMP, SUT                       6.2 (3)        0          3.5 (3)
  AMC, CFL                       0              2.7 (1)    1.2 (1)
  TET, CLO                       0              2.7 (1)    1.2 (1)
  TET, SUT                       4.2 (2)        0          2.4 (2)
  AMP, TET, SUT                  4.2 (2)        2.7 (1)    3.5 (3)
  AMP, TET, SUT, CLO             6.2 (3)        0          0
  AMP, AMC, CFL, TET             0              2.7 (1)    1.2 (1)
  GEN, TET, CIP, LVX             2.0 (1)        0          1.2 (1)
  AMP, CFL, TET CIP, LVX         2.0 (1)        0          1.2 (1)
  AMP, CFL, GEN, TET, CIP, SUT   0              2.7 (1)    1.2 (1)

AMP-ampicillin; TET-tetracycline. SUT- trimethoprim/sulfamethoxazole; CLO-chloramphenicol. CFL-cephalothin. AMC-amoxicillin/clavulanic acid; LVX-levofloxacin. CIP-ciprofloxacin;GEN-gentamicin. CRO-ceftriaxone. CTX-cefotaxime.

Multiplex PCR
-------------

The analysis of the genes encoding important virulence markers of *E. coli* revealed that none of the isolates carried the ipaH, eae, hly, bfp, LT and ST genes. [@B17], and [@B9], reported low prevalence rates of pathogenic *E. coli* in food samples.

Genetic diversity of *E. coli* isolates using pulsed-field gel electrophoresis
------------------------------------------------------------------------------

A genetic diversity analysis by PFGE of 31 resistant isolates revealed 29 distinct restriction patterns ([Figure 1](#f1){ref-type="fig"}).
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There were no strains with an indistinguishable electrophoretic pattern that could characterize a clone. The highest similarity percentage was 84.2% between the human and food isolates. Two groups (F and M) contained one human isolate and one food isolate that differed by 3 bands (*i.e.*, close related isolates). Despite the limitations, we cannot exclude the hypothesis that a food reservoir exists and that food-borne transmission of *E.coli* is common.

The genetic diversity among the *E. coli* isolates in this study can be explained by the fact that the isolates were not epidemiologically related; they had been isolated from different locations. The isolates were obtained in the same period and had some resistance characteristics. Moreover, the human isolates were obtained from outpatients who were epidemiologically unrelated. Even when studying geographically related strains, an absence of clones is possible, as reported by [@B6], who observed an absence of an endemic clone and a high diversity of *E.coli* strains isolated from humans and foods.

In practice, the typing of microorganisms is more effective as an aid during the investigation of outbreaks when applied to a low number of epidemiologically related isolates ([@B23]). However, it is necessary to study strains of different origin, especially those not involved in the outbreaks with antimicrobial resistance to assess possible modifications of their genome. Such an analysis is crucial for understanding their origin and their impact on public health and for establishing possible control strategies.

Conclusion
==========

This study, which was performed in the third largest city of Brazil, found that 34.6% of the *E. coli* isolates were antimicrobial resistant. The most frequent antibiotic resistance observed was tetracycline in both human and food isolates. In addition, we found a high percentage of multidrug resistance among these isolates, particularly in isolates obtained from humans and foods of animal origin. None of the strains was considered to be pathogenic, and the molecular typing by PFGE found a high degree of genetic diversity among the isolates.
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